Purple Biotech Ltd. (PPBT.TA)
ILA 5.1
(2.0%)
ILA 5.1
(2.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -14.13 Million USD | 2.6% |
| 2022 | -14.51 Million USD | -43.13% |
| 2021 | -10.14 Million USD | 2.04% |
| 2020 | -10.35 Million USD | -148.73% |
| 2019 | -4.16 Million USD | 19.39% |
| 2018 | -5.16 Million USD | -30.81% |
| 2017 | -3.94 Million USD | 41.6% |
| 2016 | -6.75 Million USD | 35.99% |
| 2015 | -10.55 Million USD | -936.11% |
| 2014 | -1.01 Million USD | -244.74% |
| 2013 | 704 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -9.67 Million USD | 31.55% |
| 2024 Q2 | -6.26 Million USD | 35.29% |
| 2023 FY | -14.13 Million USD | 2.6% |
| 2023 Q1 | -21.41 Million USD | -47.54% |
| 2023 Q3 | -14.73 Million USD | 12.2% |
| 2023 Q4 | -14.13 Million USD | 4.05% |
| 2023 Q2 | -16.78 Million USD | 21.64% |
| 2022 Q2 | -13.41 Million USD | 41.29% |
| 2022 Q1 | -22.84 Million USD | -125.25% |
| 2022 FY | -14.51 Million USD | -43.13% |
| 2022 Q3 | -10.52 Million USD | 21.53% |
| 2022 Q4 | -14.51 Million USD | -37.92% |
| 2021 Q1 | -9.36 Million USD | 9.52% |
| 2021 Q4 | -10.14 Million USD | -21.38% |
| 2021 FY | -10.14 Million USD | 2.04% |
| 2021 Q3 | -8.35 Million USD | 14.18% |
| 2021 Q2 | -9.73 Million USD | -3.95% |
| 2020 Q3 | -10.55 Million USD | 83.21% |
| 2020 Q2 | -62.87 Million USD | 0.17% |
| 2020 FY | -10.35 Million USD | -148.73% |
| 2020 Q1 | -62.98 Million USD | -1413.38% |
| 2020 Q4 | -10.35 Million USD | 1.96% |
| 2019 Q4 | -4.16 Million USD | 4.48% |
| 2019 FY | -4.16 Million USD | 19.39% |
| 2019 Q2 | -2.43 Million USD | 7.39% |
| 2019 Q1 | -2.62 Million USD | 49.16% |
| 2019 Q3 | -4.35 Million USD | -79.23% |
| 2018 Q4 | -5.16 Million USD | 0.0% |
| 2018 Q1 | -5.36 Million USD | -35.88% |
| 2018 Q2 | -5.36 Million USD | 0.0% |
| 2018 Q3 | -5.16 Million USD | 3.73% |
| 2018 FY | -5.16 Million USD | -30.81% |
| 2017 Q3 | -3.94 Million USD | -648.96% |
| 2017 Q4 | -3.94 Million USD | 0.0% |
| 2017 Q1 | -527 Thousand USD | 92.2% |
| 2017 FY | -3.94 Million USD | 41.6% |
| 2017 Q2 | -527 Thousand USD | 0.0% |
| 2016 Q4 | -6.75 Million USD | 0.0% |
| 2016 Q3 | -6.75 Million USD | -71.83% |
| 2016 Q2 | -3.93 Million USD | 0.0% |
| 2016 Q1 | -3.93 Million USD | 62.75% |
| 2016 FY | -6.75 Million USD | 35.99% |
| 2015 Q1 | -685 Thousand USD | 32.78% |
| 2015 Q2 | -1.65 Million USD | -141.17% |
| 2015 Q3 | -551 Thousand USD | 66.65% |
| 2015 FY | -10.55 Million USD | -936.11% |
| 2015 Q4 | -10.55 Million USD | -1816.15% |
| 2014 Q4 | -1.01 Million USD | 52.16% |
| 2014 Q1 | -2.39 Million USD | -440.2% |
| 2014 Q2 | -710 Thousand USD | 70.35% |
| 2014 Q3 | -2.13 Million USD | -200.0% |
| 2014 FY | -1.01 Million USD | -244.74% |
| 2013 Q2 | 66.29 Thousand USD | 61.69% |
| 2013 Q3 | 443 Thousand USD | 568.2% |
| 2013 Q4 | 704 Thousand USD | 58.92% |
| 2013 FY | 704 Thousand USD | 0.0% |
| 2013 Q1 | 41 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Matricelf Ltd | -835 Thousand ILA | -1593.174% |